WinNonlin: steady state setup [Software]

posted by bobmarlo – 2017-01-17 21:36 (3434 d 02:45 ago) – Posting: # 16968
Views: 14,546

Dear Helmut,
Thank you for your response. Your simulation and explanation makes complete sense to me. However, I am still curious about calculation of CL and MRT. As CL=Dose/AUC and MRT=(AUMC/AUC) - (Duration of Infusion/2). These parameters are dependent on AUC & AUMC. And the problem with AUC & AUMC I see is that baseline being 10, the calculated AUC is sum of exposure due to second dose + exposure due to the baseline concentration of drug already present, which can contribute to as high as 10% of total AUC (200 at Cmax, 10 at 0h). In this situation do you think these parameters (CL and MRT) will still be good representative of Plasma PK for this drug? or there is way to analyze it better?
Thanks again to you and Mittyri for links.
Bob


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
142 visitors (0 registered, 142 guests [including 45 identified bots]).
Forum time: 01:21 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5